Plasma Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026

Published: Apr 2022

Pages: 137

SKU: IRTNTR73076

Snapshot

The plasma therapeutics market share is expected to increase by USD 8.98 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.1%.

This plasma therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers plasma therapeutics market segmentations by product (immunoglobulin, albumin, blood factors, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The plasma therapeutics market report also offers information on several market vendors, including ADMA Biologics Inc., Bio Products Laboratory Ltd., BIOPHARMA PLASMA, CSL Ltd., Emergent BioSolutions Inc., Evolve Biologics Inc., Grifols SA, Kamada Ltd., Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd., and Takeda Pharmaceutical Co. Ltd. among others.

What will the Plasma Therapeutics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Plasma Therapeutics Market Size for the Forecast Period and Other Important Statistics

Plasma Therapeutics Market: Key Drivers, Trends, and Challenges

The high demand for albumin in China is notably driving the plasma therapeutics market growth, although factors such as existence of plasma fractionation supply and demand gap may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the plasma therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Plasma Therapeutics Market Driver

One of the key factors driving the global plasma therapeutics market growth is the high demand for albumin in China. China is one of the largest markets for albumin products in the global plasma therapeutics market, followed by the US market. The demand for plasma products, especially albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and a ban on the import of plasma products. For instance, since 1986, the Government of China has forbidden all plasma and blood-derived products from being imported into China, with the exception of human albumin. Therefore, vendors are focusing on strategic alliances to expand their presence in China. For instance, in March 2020, Grifols and Shanghai RAAS formed a strategic alliance in China. Such factors are expected to drive the growth of the market during the forecast period.

Key Plasma Therapeutics Market Trend

Establishment of plasma fractionation facilities in developing economies by global players is one of the key plasma therapeutics market trends that is expected to impact the industry positively in the forecast period. Plasma fractionation in developed countries is proving very costly, so there has been a growing focus of vendors to tap developing economies such as the Middle East, Africa, China, and India. For instance, in March 2021, China-based Oryx Biotech Holdings started the construction of a plasma fractionation plant in Bangladesh. The company invested around USD 300 million in the development of this facility. Going forward, to benefit from the unmet demand in the emerging markets and the incentives of opening such facilities in the region will drive global players to open a number of such facilities in the region. Such factors will further support the growth of the market during the forecast years.

Key Plasma Therapeutics Market Challenge

One of the key challenges to the global plasma therapeutics market growth is the existence of the plasma fractionation supply and demand gap. There is a huge demand for plasma-derived products in China; however, it is experiencing a considerable decrease in the supply of human plasma. The global plasma supply and fractionation capacity are currently constrained, and the leading players are Baxter, Grifols, and CSL Behring. The minimum capital expenditure required to set up a fractionation unit of 100,000-liter capacity is USD 100 million. In addition, the stringent regulatory framework imposed on the fractionation units is creating pressure on the investors. All these factors are expected to hinder the entry of new pharmaceutical companies, which, in turn, will negatively impact the growth of the market during the forecast period.

This plasma therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global plasma therapeutics market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the plasma therapeutics market during the forecast period.

Who are the Major Plasma Therapeutics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

This statistical study of the plasma therapeutics market encompasses successful business strategies deployed by the key vendors. The plasma therapeutics market is concentrated and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

ADMA Biologics Inc. - The company offers human immunoglobulin that is purified from source human plasma and processed using a modified classical Cohn-Oncley fractionation procedure.
ADMA Biologics Inc. - The ADMA biomanufacturing segment includes the company's immune globulin manufacturing and development operations.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The plasma therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Plasma Therapeutics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the plasma therapeutics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Plasma Therapeutics Market?

For more insights on the market share of various regions Request for a FREE sample now!

47% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for plasma therapeutics market in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The presence of a large number of key vendors such as CSL Behring, ADMA Biologics, Inc., and Biotest Pharmaceuticals Corp will facilitate the plasma therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic positively impacted the growth of the market. The number of patients that require critical care witnessed an increase due to the pandemic, which fueled the demand for critical care therapeutics, including plasma therapeutics. Moreover, in 2021, the initiation of large-scale vaccination drives and the lifting of lockdown norms helped the market to grow. Thus, the regional market is expected to witness moderate growth during the forecast period.

What are the Revenue-generating Product Segments in the Plasma Therapeutics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The plasma therapeutics market share growth by the immunoglobulin (IG) segment will be significant during the forecast period. The development of novel therapeutics to treat critical diseases will drive the growth of the market through this segment in the forecast years. For instance, CSL Behring, Takeda, and a few other vendors formed a strategic alliance in April 2020. These vendors are expected to develop IG-based medicine for critical diseases such as severe acute respiratory syndrome (SARS).

This report provides an accurate prediction of the contribution of all the segments to the growth of the plasma therapeutics market size and actionable market insights on post COVID-19 impact on each segment.

Plasma Therapeutics Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 6.1%
Market growth 2022-2026	$ 8.98 billion
Market structure	Concentrated
YoY growth (%)	5.2
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 47%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	ADMA Biologics Inc., Bio Products Laboratory Ltd., BIOPHARMA PLASMA, CSL Ltd., Emergent BioSolutions Inc., Evolve Biologics Inc., Grifols SA, Kamada Ltd., Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd., and Takeda Pharmaceutical Co. Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Plasma Therapeutics Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive plasma therapeutics market growth during the next five years
Precise estimation of the plasma therapeutics market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the plasma therapeutics industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of plasma therapeutics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product

5.3 Immunoglobulin - Market size and forecast 2021-2026
- Exhibit 28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)

5.4 Albumin - Market size and forecast 2021-2026
- Exhibit 32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)

5.5 Blood factors - Market size and forecast 2021-2026
- Exhibit 36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)

5.6 Others - Market size and forecast 2021-2026
- Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

5.7 Market opportunity by Product
- Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.10 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.11 China - Market size and forecast 2021-2026
- Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 87: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 88: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 89: Overview on factors of disruption

9.4 Industry risks
- Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 91: Vendors covered

10.2 Market positioning of vendors
- Exhibit 92: Matrix on vendor position and classification

10.3 ADMA Biologics Inc.
- Exhibit 93: ADMA Biologics Inc. - Overview
- Exhibit 94: ADMA Biologics Inc. - Business segments
- Exhibit 95: ADMA Biologics Inc. - Key offerings
- Exhibit 96: ADMA Biologics Inc. - Segment focus

10.4 Bio Products Laboratory Ltd.
- Exhibit 97: Bio Products Laboratory Ltd. - Overview
- Exhibit 98: Bio Products Laboratory Ltd. - Product / Service
- Exhibit 99: Bio Products Laboratory Ltd. - Key offerings

10.5 CSL Ltd.
- Exhibit 100: CSL Ltd. - Overview
- Exhibit 101: CSL Ltd. - Business segments
- Exhibit 102: CSL Ltd. - Key news
- Exhibit 103: CSL Ltd. - Key offerings
- Exhibit 104: CSL Ltd. - Segment focus

10.6 Grifols SA
- Exhibit 105: Grifols SA - Overview
- Exhibit 106: Grifols SA - Business segments
- Exhibit 107: Grifols SA - Key offerings
- Exhibit 108: Grifols SA - Segment focus

10.7 Kamada Ltd.
- Exhibit 109: Kamada Ltd. - Overview
- Exhibit 110: Kamada Ltd. - Product / Service
- Exhibit 111: Kamada Ltd. - Key offerings

10.8 Kedrion Spa
- Exhibit 112: Kedrion Spa - Overview
- Exhibit 113: Kedrion Spa - Product / Service
- Exhibit 114: Kedrion Spa - Key offerings

10.9 Octapharma AG
- Exhibit 115: Octapharma AG - Overview
- Exhibit 116: Octapharma AG - Product / Service
- Exhibit 117: Octapharma AG - Key offerings

10.10 Prothya Biosolutions Netherlands BV
- Exhibit 118: Prothya Biosolutions Netherlands BV - Overview
- Exhibit 119: Prothya Biosolutions Netherlands BV - Product / Service
- Exhibit 120: Prothya Biosolutions Netherlands BV - Key offerings

10.11 SK Discovery Co. Ltd.
- Exhibit 121: SK Discovery Co. Ltd. - Overview
- Exhibit 122: SK Discovery Co. Ltd. - Product / Service
- Exhibit 123: SK Discovery Co. Ltd. - Key offerings

10.12 Takeda Pharmaceutical Co. Ltd.
- Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 127: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 128: Inclusions checklist
- Exhibit 129: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 130: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 131: Research methodology
- Exhibit 132: Validation techniques employed for market sizing
- Exhibit 133: Information sources

11.5 List of abbreviations
- Exhibit 134: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

plasma therapeutics market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis